Margin strength amid tariff pause; H2 recovery backed by ₹570 Cr order book
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B+
Reaffirmed ₹2,000 Cr FY27 guidance from prior call; Q1 soft but margins expanded, not profit miss.
Optimistic
next 1–2 quarters
Optimistic
multi-year
S.P. Apparels delivers operational excellence amid a soft quarter: flat revenue but margins expanded to 15.3% on better product mix and efficiency. FY27 guidance of ₹2,000 Cr is maintained, backed by ₹570 Cr order book and post-tariff tailwinds. Key risk: H2 growth must materialize to justify guidance and multiyear targets (SPUK GBP 50M in 5 years).
₹401.1 Cr
Revenue · −0.6% YoY₹24.9 Cr
Reported PAT · +20.4% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Q1 profitability improved meaningfully
PAT +20.4% YoY to ₹24.9 Cr; EBITDA margin 15.3% vs 13.1% YoY
MET
FY27 guidance of ₹2,000 Cr consolidated revenue achievable
Q1 ₹401 Cr flat YoY; order book ₹570 Cr covers 4–5 months; targets H2 for bulk growth
Partially Corroborated—Requires H2 Delivery
SPUK 125% YoY growth demonstrates traction
₹33.3 Cr revenue (vs ₹14.8 Cr prior year); EBITDA negative ₹1.04 Cr due to timing/air freight
Supported On Volume, Not Profitability Yet
Margins driven by efficiency and product mix, not one-offs
Garment EBITDA margin 17.6% despite lower utilization; ₹1.75 Cr forex loss normalized away
MET
Sri Lanka facility operationally comparable to India by end of FY27
₹25 Cr revenue Q1, 1,300 machines used for export, expected ₹150–200 Cr by FY-end
On Track But Still Integration Phase
Earnings quality
What changed since the last call
Customer base for SPUK expanded
UpgradeAdded 3 new brands including Marks & Spencer; SPUK customers grew to 7 (4 existing + 3 new)
Sri Lanka revenue guidance raised
UpgradeFrom concept to ₹25 Cr Q1; projected ₹150–200 Cr by FY-end vs no prior explicit range
Young Brand expansion accelerated
UpgradeNew facilities online by October; bra product capex ₹10 Cr max; FY27 target ₹340–350 Cr
Order book disclosed
New₹570 Cr total order book (SPAL ₹430 Cr, YBA ₹100 Cr, SPUK ₹70 Cr); covers 4–5 months at planned run rate
Tariff impact quantified and dated
NeutralJan–May 2026 headwind attributed to U.S. tariff uncertainty; rollback underway; some orders withheld by customers awaiting reversal clarity
The Q&A
Analysts pressed on capacity utilization drop, margin sustainability, execution risk on aggressive expansion, and achievability of ₹2,000 Cr in weak H1. Management held firm with conviction and specific numbers; deflected on customer names (confidentiality till shipment); tone remained composed.
Capacity utilization — Varun, Equitree Capital
Answered750 new machines added in FY27 (dilutes base); tariff issues Jan–May 2026 caused order slowness. Delays were customer-requested, not container-related. No spillover expected into Q2.
New customers & SPUK growth — Prerna Jhunjhunwala, Elara Securities
PartialCannot disclose until first shipment. 2 from UK, 1 from EU. SPUK guidance: GBP 13M in 3 years, GBP 50M in 5 years. Marks & Spencer mentioned as anchor customer.
Sri Lanka traction — Prerna Jhunjhunwala, Elara Securities
Answered1,650 machines, 85–90% capacity. ₹25 Cr Q1 revenue. Expected ₹150–200 Cr by FY-end. Operationally on time; pre-operative losses normalizing by March. Systems integrated; managed from India.
Margin normalization — Raman KV, Sequent Investments
AnsweredNo one-offs. Driven by product mix improvement and better efficiency. Guided for 15%+ margin full year.
US tariff outlook — Amish Kanani, Knowise
AnsweredCautiously optimistic. Customers not expecting further tariff escalation but uncertain. Orders booked till January; wait-and-watch thereafter. Order book safe at ₹570 Cr.
FY27 ₹2,000 Cr achievability — Rehan, Coheron Wealth
AnsweredYes. Lost revenue in H1 will be recovered in H2. Second half is when bulk growth will come, supported by order inflows and normalized schedules. Order book backs confidence.
Guidance
FY27 consolidated ₹2,000 Cr (maintained)
HighH1 softer due to tariffs; H2 expected to be stronger. Order book ₹570 Cr provides visibility. Reiterated multiple times on call.
Infant export (SPAL) ₹1,300–1,400 Cr FY27 (vs ₹1,100 Cr FY26)
High18–27% growth. Driven by tariff rollback, FTA benefits, order book ₹430 Cr.
Young Brand ₹340–350 Cr FY27 (vs ₹300 Cr FY26)
Medium13–17% growth. New facilities online by October; bra product launch adds upside. Still in ramp phase.
SPUK GBP 13M in 3 years; GBP 50M in 5 years
MediumCurrently ₹33 Cr (₹250–300M GBP equivalent). Marks & Spencer anchor; 7 customers; ambitious but potential credible given FTA tailwind.
Sri Lanka ₹150–200 Cr by FY-end (from ₹25 Cr Q1)
MediumAggressive ramp; 6–8x growth in 3 quarters. Backed by order flow from India; pre-operative losses normalizing.
Garment division EBITDA margin ≥15% FY27 (above prior guidance of 15%)
HighQ1 at 17.6%; guided as normalized level above 15%. Supported by product mix and efficiency.
Consolidated EBITDA margin 14–15% FY27 (from prior FY26 calls)
HighQ1 consolidated 15.3%; on track. SPUK and Retail losses offset by garment strength.
SPUK sustainable EBITDA by scale (currently negative ₹1.04 Cr)
MediumManagement: 'Already EBITDA positive sans timing/air freight.' Trading model—fixed cost absorption on higher volume.
Young Brand bra product line ₹10 Cr max investment
HighStarting Sep–Oct 2026; full production FY28. 200 machine capacity; machinery acquisition + team.
Total capacity target 10,000 machines: 6,000 India, 2,000 Sri Lanka, 1,750 Young Brand
HighReady for next 2–3 years of growth. India: +300 machines over 2 years post Salem. Sri Lanka: +500–600 job-work machines.
Risks the call surfaced
Tariff and geopolitical
MediumTariff headwinds caused order slippage in Jan–May 2026. Young Brand saw 5.2M vs 5M pieces sequential (flat). Customers holding back orders; orders booked only till January 2027. New tariff bill passed in Congress adds uncertainty.
Execution risk
MediumPlan to add 10,000 machines across geographies; Sri Lanka ramp ₹150–200 Cr by FY-end (6–8x growth); Young Brand capacity online by Oct; bra product line launch; 3 new SPUK customers to integrate. Multiple moving parts.
Profitability of new ventures
MediumSPUK: ₹33.3 Cr revenue, -₹1.04 Cr EBITDA (negative). Retail: ₹18.83 Cr revenue, ₹0.41 Cr EBITDA (barely breakeven). Both loss-making or low-margin. Path to profitability requires scale.
Customer concentration
LowCompany added 7 customers for SPUK; diversified to 15+ for garmenting. But new customers (Marks & Spencer, 3 recent U.K. brands) are not yet in full contribution. Ramp timing uncertain.
Sri Lanka integration
MediumSri Lanka facility: 1,650 machines, 85–90% capacity, but pre-operative losses ongoing. Expected to reach breakeven by March 2027. Integration of HR, accounts, operations, payments from India adds complexity.
Management
Score 8/10. Clear, specific, numbers-backed. Addressed all questions directly. Declined to name customers (confidentiality justified), but provided quantified targets (GBP 50M, ₹2,000 Cr, order book ₹570 Cr). No corporate jargon. On track to FY27 ₹2,000 Cr guidance; tariff headwinds acknowledged and attributed to external cause, not operational miss. Margins expanded 220 bps despite soft revenue—operational discipline evident. Sri Lanka ramp credible (₹25 Cr → ₹150–200 Cr pipeline real). Young Brand executing facility rollout on schedule.
1 · Q2 FY27
Revenue expected better than Q1; tariff benefit materializes
2 · Sep–Oct 2026
Young Brand all units commercial production; bra product line launch
3 · Dec 2026
EU-India FTA expected to be signed; new sourcing flows
Key risk: H2 growth must materialize to justify guidance and multiyear targets (SPUK GBP 50M in 5 years).
Margins soar, revenue stalls — management bets H2 delivers the quarter's growth
S.P. Apparels posted PAT up 20.4% YoY on margin expansion, but revenue flat at ₹401 Cr. Guidance for ₹2,000 Cr FY27 maintained without upgrade. The market has priced in skepticism: stock down 12.77% by day 3. Everything hinges on unbooked H2 growth.
₹401.1 Cr
-0.6% YoY | +9.9% QoQ
₹24.9 Cr
+20.4% YoY | +33.8% QoQ
17.6%
+230 bps YoY
15.3%
+220 bps YoY
The profit-growth story is real, but it masks a deeper problem: S.P. Apparels delivered earnings expansion without revenue growth. PAT rose 20.4% YoY while revenue stayed flat. That tells you the quarter was driven by margin mix and efficiency, not volume — the opposite of what the ₹2,000 Cr FY27 guidance needs.
Where the profit came from: operational excellence, not growth
The garment division's EBITDA margin expanded 230 basis points to 17.6% despite utilization dropping 14% YoY (due to 750 new machines added in FY27 diluting the base). Management attributed the flat revenue to tariff-driven order slowness in Jan–May 2026, not operational stumble. That's credible: the order book stands at ₹570 Cr covering 4–5 months at planned run rate, and management detailed exactly which customers withheld orders awaiting tariff clarity (not a container crunch or facility issue). Standalone adjusted EBITDA margin (ex one-time ₹1.75 Cr forex impact in packing credit) was 17.5%, suggesting the earnings quality is sustainable.
However, profits grew while revenue was flat. That margin story is powerful for a quarter, but it's not a growth story. And guidance of ₹2,000 Cr FY27 requires growth—specifically, H2 to deliver nearly ₹600+ Cr more than H1 to hit the target. The company reaffirmed this guidance without raising it, which is telling: management is confident but not overextending.
Q1 profitability improved meaningfully
PAT +20.4% YoY to ₹24.9 Cr; EBITDA margin 15.3% vs 13.1% prior year
Supported
₹2,000 Cr FY27 guidance is achievable
Q1 ₹401 Cr flat YoY; order book ₹570 Cr covers 4–5 months; H2 unbooked but management confident
Partially corroborated — requires H2 delivery
Margins driven by efficiency and product mix, not one-offs
Garment EBITDA 17.6% despite lower utilization; ₹1.75 Cr forex loss normalized away
Supported
Sri Lanka facility operationally on track by end-FY27
₹25 Cr Q1 revenue, 1,650 machines at 85–90% capacity, projected ₹150–200 Cr FY-end
On track but still integration phase
SPUK +125% YoY growth demonstrates traction
₹33.3 Cr revenue (+125% YoY); EBITDA negative ₹1.04 Cr due to air freight and timing
Supported on volume; profitability deferred
What changed on this call
Three upgrades to the forward story: (1) Marks & Spencer signed for SPUK sourcing, anchoring the U.K. retail/trading arm with a marquee customer and multi-year volumes; (2) Sri Lanka facility ramp visible — ₹25 Cr Q1 revenue with ₹150–200 Cr FY-end guidance (6–8x growth in three quarters) replaces prior concept stage; (3) Order book disclosed for the first time — ₹570 Cr total (SPAL ₹430 Cr, Young Brand ₹100 Cr, SPUK ₹70 Cr) provides transparency on near-term revenue visibility. Young Brand facilities expected online by October; bra product capex capped at ₹10 Cr max. The company also quantified tariff drag, pinpointing Jan–May 2026 as the period of customer order delays and confirming no spillover expected into Q2.
The guidance bet: everything rides on H2 execution
Reaffirmed FY27 consolidated revenue of ₹2,000 Cr, with specific segment targets: SPAL infant export ₹1,300–1,400 Cr (18–27% growth), Young Brand ₹340–350 Cr (13–17% growth), SPUK GBP 13M in three years (currently ₹33 Cr), Sri Lanka ₹150–200 Cr. Consolidated EBITDA margin guided for 14–15% full year. On paper, the targets look disciplined. In practice, the order book of ₹570 Cr covers only 4–5 months of run rate, leaving roughly 7–8 months of H2 unbooked. Management is betting that tariff rollback (underway) and FTA benefits (U.K. live, EU expected by year-end) will unlock sufficient customer orders to close the gap. This is a conviction play, not a hedge.
Garment EBITDA 17.6% despite capacity dilution proves operational edge
Marks & Spencer anchor customer de-risks SPUK scaling
Order book ₹570 Cr covers only 4–5 months; H2 unbooked
SPUK EBITDA negative ₹1.04 Cr; Retail barely breakeven; Sri Lanka pre-operative losses
FY27 guidance maintained without upgrade, suggesting prudence or lack of confidence
Tariff benefit dependent on external catalysts (reversal, FTA timing) outside company control
Management tone confident, numbers specific, no deflection on execution
Capex heavy (₹100+ Cr FY27); returns delayed; multi-year payoff uncertain
The street's read: skepticism priced in
The market has delivered its own verdict: stock down 12.77% by day 3 post-result announcement, compared to pre-result close of ₹1,074.5. This is not a routine profit-warning decline—it's a structural dismissal. At ₹932.45 (as of Aug 17), the stock sits 23.69% below its all-time high of ₹1,221.9, yet 55.41% above its 52-week low. Technicals are mixed: price below SMA20 and SMA50 (near-term weakness) but above SMA200 (longer-term uptrend intact). RSI at 42.5 is neutral, not oversold—there's room to run either direction.
Ownership flows confirm the skepticism: DII holdings declined 42 basis points QoQ (from 16.57% to 16.15%), while FII holdings remained flat at 1.49%. Promoters unchanged at 61.81%. The DII selling into profit growth is notable—institutional investors don't believe the H2 story. No bulk or insider selling signals alarm (largest recent trades were NK Securities buying and selling in June at ₹896–897 per share, well below current price), but the absence of buying pressure is telling.
Valuation: At current price, the stock is down from the highs but no longer in free fall. If H2 delivers ₹600+ Cr growth and ₹2,000 Cr FY27 is achieved, the street will re-rate the stock sharply upward (likely back to ₹1,100+). If H2 orders don't flow and guidance is missed, the stock re-tests ₹700–800. The risk-reward is binary, not balanced.
H2 orders not flowing; ₹2,000 Cr guidance missed
HighUnbooked H2 (7–8 months of the 6-month half) must deliver ₹600+ Cr to hit target. If tariff reversal stalls or FTA delays, customer orders won't materialize. Guidance miss triggers sharp re-rating.
U.S. tariff bill reversal uncertain; orders booked only till Jan 2027
HighJan–May 2026 drag attributed to tariff uncertainty; customers holding back. New tariff bill passed Congress with unclear implementation. If reversal stalls, Young Brand (100% U.S. market) and SPAL customers delay fresh orders.
SPUK profitability deferred; cash burn masked by top-line growth
MediumSPUK EBITDA negative ₹1.04 Cr on ₹33.3 Cr revenue. Management says timing/air freight one-time, but underlying trading model has thin margins. Scale to GBP 50M (5-year target) requires flawless execution.
Sri Lanka integration ongoing; pre-operative losses persist
Medium₹25 Cr Q1 revenue with pre-operative losses; expected to normalize by March. Ramp to ₹150–200 Cr FY-end is aggressive (6–8x growth in 3Q). If integration stumbles or cost control slips, losses extend into FY28.
Execution on ₹10k-machine capacity expansion + Young Brand ramp + bra product launch
MediumMultiple moving parts in parallel. Capex heavy (₹100+ Cr FY27). Returns delayed. Any one failure (delayed facility opening, bra product flop, equipment issue) cascades into revenue miss.
EU-India FTA signing delayed; expected end-FY27 but timing uncertain
Low–MediumFTA benefit is a tailwind, not a dependency. Delay slips upside into FY28 but doesn't derail core SPAL growth. Lower severity because tariff reversal benefit already priced into Q1–Q2 orders.
1 · Q2 revenue vs. Q1: the tariff reversal test
Management guided for Q2 to be better than Q1. Tariff reversal benefit should flow through in order book. If Q2 is flat or lower than Q1 (₹401 Cr), the H2 bet collapses. Watch the SPAL infant export segment specifically—this is where tariff upside lives.
2 · Order book update and customer traction
By Oct–Nov, watch for management commentary on new orders received. Marks & Spencer first shipment is a key milestone. 3 new U.K./EU brands must begin shipments. If order pipeline slows or new customers stall, H2 growth is at risk.
3 · Young Brand facilities online by Oct; bra product ramp Dec onward
Capacity coming online but demand must follow. Monitor Young Brand revenue and margin. Bra product launch is a new SKU upside but carries execution risk. Full production FY28.
4 · FTA timing: U.K. live, EU by year-end
U.K. FTA is already in effect; EU expected by end-FY27. Watch for new customer wins and order inflows from EU-sourced brands. FTA is a structural tailwind but its magnitude and timing are variable.
5 · Sri Lanka revenue tracking ₹150–200 Cr FY-end
Q1 delivered ₹25 Cr. Q2–Q4 combined must deliver ₹125–175 Cr for management guidance to hold. Monitor utilization, capex, and pre-operative losses. By March 2027, Sri Lanka should reach self-sustainability (management target).
S.P. Apparels has proven operational excellence—a 230 basis point margin expansion while revenue stayed flat is not accidental. But operational excellence is not the same as growth delivery. The quarter was about mix and efficiency; FY27 guidance requires volume growth, and H2 is now carrying a full year's growth target on its own shoulders.
The company is not dishonest about the risk. Management reaffirmed guidance without raising it, disclosed the order book for the first time, quantified tariff drag, and backed up claims with specific numbers (Marks & Spencer, ₹570 Cr order book, facilities coming online by October). The tone is confident but realistic. However, the market has translated this into skepticism: DII is selling, and the stock is down 23% from ATH. That's not irrational—it's the street's way of saying 'prove the H2 story first.'
The valuation is now interesting. At ₹932 (55% above the 52-week low), the stock offers a trade-off: If H2 delivers ₹600+ Cr growth and guidance holds, expect a sharp re-rate to ₹1,100+. If orders don't flow and guidance is missed, expect a retest of ₹700–800. This is binary, not a steady-state hold.
The number to track from here is Q2 revenue. It's the canary in the coal mine. If Q2 is better than Q1 (₹401 Cr) and trending toward ₹450+ Cr, the H2 story gains traction. If Q2 is flat or lower, the guidance unravels and the stock re-rates down. Everything else—order book, facilities, new customers—flows from whether the order flow actually accelerates. The operational excellence is proven; the growth bet is not.
S.P. Apparels: consolidated PAT +20% YoY to ₹24.9 Cr, margins expand to 15.3%
PAT +20.43% YoY · revenue -0.59% · margins expanding · beat vs street
₹401.08 Cr
-0.59% YoY
₹24.87 Cr
+20.43% YoY
6.15%
+1.1pp YoY
₹9.89
S.P. Apparels' consolidated (primary) revenue for Q1 FY27 was ₹401.1 Cr, essentially flat YoY (-0.6% vs ₹403.4 Cr in Q1 FY26) though up 9.9% QoQ off a seasonally softer Q4 FY26 (₹364.9 Cr). Consolidated PAT of ₹24.9 Cr grew 20.4% YoY (₹20.7 Cr in Q1 FY26) and 33.8% QoQ (₹18.6 Cr in Q4 FY26), with EPS at ₹9.89 vs ₹8.23 a year ago. Both revenue (~₹401 Cr) and PAT (~₹24.9 Cr) came in above the ₹344-396 Cr revenue and ₹12-15 Cr PAT ranges flagged in a pre-result Univest preview — a beat on both lines, though that preview was a trailing-growth projection, not a formal brokerage estimate. Management's own press release highlights the more flattering comparison for each basis — QoQ (+33.8%) on consolidated PAT and YoY (+33.4%) on standalone PAT — while the less-flattering consolidated YoY (+20.4%) isn't called out; the underlying numbers agree with management's figures, just not their framing.
Q1 FY-2027 vs prior quarters
The growth was entirely a margin story. Consolidated NPM expanded to 6.2% from 5.1% a year ago, and the company's own disclosed EBITDA margin rose to 15.3% from 12.94% in Q1 FY26 (and 12.2% in Q4 FY26) — already at or above the 14-15% consolidated EBITDA margin band management guided for FY27, one quarter in. Standalone PAT of ₹26.5 Cr grew faster, +33.4% YoY, aided by standalone finance costs falling to ₹2.4 Cr from ₹7.2 Cr a year ago; consolidated finance costs instead rose to ₹14.9 Cr from ₹11.8 Cr, pointing to debt shifting toward the UK subsidiary — consistent with the loan agreement executed and then terminated with S.P. Apparels UK during the quarter and the ₹12.51 Cr corporate guarantee extended to it. That subsidiary's EBITDA stayed negative (₹(1.0) Cr) even as its revenue jumped 125% YoY to ₹33.3 Cr, so consolidated PAT growth (+20.4% YoY) trails the standalone print (+33.4%) by more than the usual divergence threshold, with the UK operation the drag.
The stock went into the print at ₹1,074.5, down 4.5% over the past month of trading.
Management projects a consolidated revenue of INR 2000 crores for FY27, targeting a 14%-15% EBITDA margin on a consolidated basis. The Garmenting division is expected to contribute INR 1800 crores with a 15% EBITDA margin, while SPUK and Retail Ventures are projected to bring in INR 150 crores and INR 80-90 crores resp
— This quarter: met
On the FY27 revenue target of ₹2,000 Cr consolidated (₹1,800 Cr Garmenting, ₹150 Cr SPUK, ₹80-90 Cr Retail Ventures), Q1's ₹401 Cr is roughly a fifth of the annual number — too early to call a miss but behind a straight-line pace, even as the margin band is already being met. Alongside results, the board recommended a final FY26 dividend of ₹3/share and approved a 1:5 stock split (face value ₹10 to ₹2, pending shareholder approval at the September 21, 2026 AGM) — moves aimed at broadening retail participation, not signals on operating performance. Segment-wise, the Garmenting division (incl. Young Brand Apparel) posted an adjusted EBITDA margin of 17.6% on ₹337.3 Cr revenue, S.P. Retail Ventures grew revenue 26.7% YoY to ₹18.8 Cr, and export volumes were 15.7 million pieces (S.P. Apparels) plus 5.0 million pieces (Young Brand Apparels) for the quarter.
W1
FY27 guidance of ₹2,000 Cr consolidated revenue at 14-15% EBITDA margin — Q1's ₹401 Cr is ~20% of the annual target; watch whether the Garmenting division (guided ₹1,800 Cr) accelerates through the year
W2
SPUK stayed EBITDA-negative (₹(1.0) Cr) this quarter despite a new/terminated UK loan agreement and a ₹12.51 Cr corporate guarantee — watch whether it turns EBITDA-positive against its ₹150 Cr FY27 revenue target
W3
Execution of the 1:5 stock split (record date pending shareholder approval at the Sept 21, 2026 AGM, tentatively ~2 months to complete post-approval)
Figures converted from ₹ Millions (÷10). Consolidated PBT nets a ₹(0.87) Cr share-of-associate loss before tax. Consolidated 'Minority Interest' line (₹(0.04) Cr) applies only to Other Comprehensive Income, not PAT — reported PAT of ₹24.874 Cr (line 16) matches the company's own press release. No exceptional/one-off items in either statement.